The former director of Techni-Pro Institute nursing school in Boca Raton is facing up to 20 years in prison after being found ...

Medicus Pharma Ltd. (Nasdaq:MDCX) is a precision guided biotech/life sciences company focused on accelerating the clinical ...

Crown Point, Ind.-based OYE Therapeutics has closed a $5 million convertible note financing round, oversubscribed to $5.6 million, to advance its intravenous caffeine-based therapy into clinical ...

High-sensitivity C-reactive protein (CRP) decreased significantly in the semaglutide group, with estimated treatment ratios ...

As 2026 approaches, the clinical research and development landscape is evolving beyond traditional scientific innovation with ...

Post-hoc analysis of RAP-219 Phase 2a data showed early onset of action and consistency of median response over the entire treatment period, ...

—Long-term Phase 1/2a and open label extension (OLE) data for zorevunersen on top of standard of care anti-seizure medicines (ASMs) demonstrate durable seizure reductions, including increases in ...

A deep analysis of semaglutide’s phase 3 AD trials shows no cognitive or functional benefit despite biomarker gains, yet ...

Researchers at the University of Colorado Cancer Center have discovered a novel therapy combination that could offer new hope ...

The new trial, funded by Pfizer, compared the company’s mRNA shot to Fluzone, one of the most widely used seasonal flu vaccines in the U.S. More than 18,000 adults, most of them in the U.S., were ...

When the Trump administration brutally cut federal funding for biomedical research earlier this year, at least 383 clinical trials that were already in progress were abruptly canceled, cutting off ...

Altering a single gene may help people lower dangerously high levels of cholesterol and other fats in the blood, according to new research presented Saturday at the annual meeting of the American ...